Page last updated: 2024-11-04

temozolomide and Intracranial Hemorrhages

temozolomide has been researched along with Intracranial Hemorrhages in 1 studies

Intracranial Hemorrhages: Bleeding within the SKULL, including hemorrhages in the brain and the three membranes of MENINGES. The escape of blood often leads to the formation of HEMATOMA in the cranial epidural, subdural, and subarachnoid spaces.

Research Excerpts

ExcerptRelevanceReference
"Thromboembolic events, seizures, neurologic symptoms and adverse effects from corticosteroids and chemotherapies are frequent clinical complications seen in Glioblastoma (GB) patients."1.42Risk factors for glioblastoma therapy associated complications. ( Brenke, C; Capper, D; Ening, G; Osterheld, F; Schmieder, K, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ening, G1
Osterheld, F1
Capper, D1
Schmieder, K1
Brenke, C1

Other Studies

1 other study available for temozolomide and Intracranial Hemorrhages

ArticleYear
Risk factors for glioblastoma therapy associated complications.
    Clinical neurology and neurosurgery, 2015, Volume: 134

    Topics: Age Factors; Antineoplastic Agents; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Cohort Studies; Da

2015